The thrombin potential (TP) has been defined as the time integral of (i.e. the area under) the thrombin generation curve. It has been shown that this parameter decreases with all types of anticoagulant treatment and increases with ATIII deficiency.
We evaluated the use of this parameter for detection of the hypercoagulative state known to accompany oral contraception.
In fresh frozen control plasma the TP could be determined with high reproducibility (n = 82, c.v. 2.9%). The TP was linearly diminished by mixing fresh frozen plasma with prothrombin deficient plasma while a high coefficient of correlation was observed (r = 0.997).
Women using oral contraceptives showed a significantly (p <0.0001) higher TP (TP = 569 nM·min, SD = 55, n = 17), compared to men or, to women not using oral contraceptives (TP = 484 nM·min, SD = 52, n = 41).
This suggests that the thrombin potential indicates the prethrombotic state known to exist in women using oral contraceptives.
References
1
Hemker HC,
Béguin S.
How to measure the relevant effect of anticoagulant treatment of the coagulability of plasma. In: Thrombosis and its management.
Poller L,
Thomson JM.
eds.
Edinburgh: Churchill Livingstone; 1993: 03-14
2
Pieters J,
Willems G,
Hemker HC,
Lindhout T.
Inhibition of factor IXa by antithrombin III/heparin during X activation. J Biol Chem 1988; 263: 15313-15318
3
Béguin S,
Mardiguian J,
Lindhout T,
Hemker HC.
The mode of action of low molecular weight heparin preparation (PK10169) and two of its major components on thrombin generation in plasma. Thromb Haemostas 1989; 61: 30-34
6
Hemker HC,
Willems GM,
Béguin S.
A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemostas 1986; 56: 09-17
7
Von KaullaE,
Droegemueller W,
Aolie N,
von KaullaKN.
Antithrombin III depression and thrombin generation acceleration in women taking oral contraceptives. Am J Obstet Gynec 1971; 109: 868-873
8
Hemker HC,
Wielders S,
Béguin S.
The thrombin potential. From Fraxiparine, second international world symposium. Recent pharmacological and clinical data New York: Schattauer; 1990: 089-101
9
Ma Xi,
Béguin S,
Hemker HC.
The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemostas 1989; 62: 788-791
11
Hemker HC,
Béguin S.
Mode of action of unfractionated and low molecular weight heparins on the generation of thrombin in plasma. Hemostasis 1990; 20 (Suppl. 01) 81-92
12
Béguin S,
Kessels H,
Dol F,
Hemker HC.
The consumption of antithrombin III during coagulation, its consequences for the calculation of prothrombinase activity and the standardization of heparin activity. Thromb Haemostas 1992; 68: 136-142
20
Hemker HC,
Wielders S,
Kessels H,
Béguin S.
Continuous registration of thrombin generation in plasma, its use for the determination of the endogenous thrombin potential. Thromb Haemostas. 1993. accepted for publication
